Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
Respirology (Carlton, Vic.)
|
April 23, 2021
Preoperative pirfenidone in idiopathic pulmonary fibrosis: A wound and injury enigma
Yet H Khor
Annals of the American Thoracic Society
|
June 20, 2025
Making Sense of Dyspnea in Interstitial Lung Disease
Yet H Khor
Respirology (Carlton, Vic.)
|
April 2, 2024
Systemic lupus erythematosus: Adding another piece to the connective tissue disease-associated interstitial lung disease puzzle
Yet H Khor
Chest
|
November 8, 2021
Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis: Combining Real World and Clinical Trials for Totality of Evidence
Yet H Khor
Respirology (Carlton, Vic.)
|
August 2, 2021
Pulmonary fibrosis: Where from and where to?
Yet H Khor
ERJ Open Research
|
November 19, 2025
Patient education and self-management in interstitial lung disease: why and what, now how?
Yet H Khor
Annals of the American Thoracic Society
|
April 1, 2022
Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
Yet H Khor, Ayodeji Adegunsoye
The European Respiratory Journal
|
February 6, 2025
Drug-induced lung disease: unwanted collateral damage
Yet H Khor, Martin Kolb
The Lancet. Respiratory Medicine
|
October 3, 2025
Hedgehog signalling: on the way to curing idiopathic pulmonary fibrosis
Paolo Spagnolo, Yet H Khor
Expert Review of Respiratory Medicine
|
July 10, 2024
The benefits and drawbacks of home oxygen therapy for COPD: what's next?
Yet H Khor, Magnus Ekström
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
Respirology (Carlton, Vic.)
|
April 23, 2021
Preoperative pirfenidone in idiopathic pulmonary fibrosis: A wound and injury enigma
Yet H Khor
Annals of the American Thoracic Society
|
June 20, 2025
Making Sense of Dyspnea in Interstitial Lung Disease
Yet H Khor
Respirology (Carlton, Vic.)
|
April 2, 2024
Systemic lupus erythematosus: Adding another piece to the connective tissue disease-associated interstitial lung disease puzzle
Yet H Khor
Chest
|
November 8, 2021
Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis: Combining Real World and Clinical Trials for Totality of Evidence
Yet H Khor
Respirology (Carlton, Vic.)
|
August 2, 2021
Pulmonary fibrosis: Where from and where to?
Yet H Khor
ERJ Open Research
|
November 19, 2025
Patient education and self-management in interstitial lung disease: why and what, now how?
Yet H Khor
Annals of the American Thoracic Society
|
April 1, 2022
Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
Yet H Khor, Ayodeji Adegunsoye
The European Respiratory Journal
|
February 6, 2025
Drug-induced lung disease: unwanted collateral damage
Yet H Khor, Martin Kolb
The Lancet. Respiratory Medicine
|
October 3, 2025
Hedgehog signalling: on the way to curing idiopathic pulmonary fibrosis
Paolo Spagnolo, Yet H Khor
Expert Review of Respiratory Medicine
|
July 10, 2024
The benefits and drawbacks of home oxygen therapy for COPD: what's next?
Yet H Khor, Magnus Ekström
Page
of 11